TuHURA Biosciences secures $50 million credit facility, royalty deal extends cash runway into 2028
PUBT · 05/15 21:01
Share
Listen to the news
- TuHURA Biosciences entered a $50 million credit facility and royalty transaction in April 2026, extending anticipated cash runway into 2028.
- Facility allows drawdowns as needed to fund monthly operating expenses tied to clinical development and operations.
- Borrowings carry 12% annual interest on drawn amounts, paid monthly.
- Principal repayment due at 5-year maturity on April 21, 2031.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tuhura Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605151700PR_NEWS_USPR_____LA61111) on May 15, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending